Establishment of a new rat model of chronic cyclosporine A nephrotoxicity

Acta Academiae Medicinae Sinicae

Volumn 32, Issue 2, 2010, Pages 205-209

  Sun, Qiao Ling ^a,b   Chen, Yi Pu ^b   Rui, Hong Liang ^b  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Adrenalectomy; Aldosterone; Cyclosporine A; Drug toxicity

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; CREATININE; CYCLOSPORIN A; DEXAMETHASONE; PLACEBO; POTASSIUM; SODIUM;

ADRENALECTOMY; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE URINE LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC TOXICITY; CONTROLLED STUDY; CREATININE CLEARANCE; GENE EXPRESSION; HYPERKALEMIA; HYPONATREMIA; KALIURESIS; KIDNEY FIBROSIS; MALE; NATRIURESIS; NEPHROTOXICITY; NONHUMAN; POSTOPERATIVE PERIOD; POTASSIUM BLOOD LEVEL; POTASSIUM URINE LEVEL; PROTEINURIA; RAT; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL;

ACUTE KIDNEY INJURY; ADRENALECTOMY; ALDOSTERONE; ANIMALS; CYCLOSPORINE; DISEASE MODELS, ANIMAL; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77952847194     PISSN: 1000503X     EISSN: None     Source Type: Journal    
DOI: 10.3881/j.issn.1000-503X.2010.02.016     Document Type: Article

References (15)

1. Feria I, Pichardo I, Juárez P, et al. Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity [J]. Kidney Int, 2003, 63(1):43-52. (Pubitemid 35463905)
2. Perez-Rojas JM, Derive S, Blanco JA, et al. Renocortical mRNA expression of vasoactive factors during spironolactone protective effect in chronic cyclosporine nephrotoxicity [J]. Am J Physiol Renal Physiol, 2005, 289(5):F1020-F1030. (Pubitemid 41447057)
3. Stanton B, Giebisch G, Klein-Robbenhaar G, et al. Effects of adrenalectomy and chronic adrenal corticosteroid replacement on potassium transport in rat kidney [J]. J Clin Invest, 1985, 75(4): 1317-1326. (Pubitemid 15087162)
4. Rosen S, Greenfeld Z, Brezis M. Chronic cyclosporine-induced nephropathy in the rat A medullary ray and inner stripe injury [J]. Transplantation, 1990, 49(2):445-452. (Pubitemid 20088191)
5. Pichler RH, Franceschini N, Young BA, et al. Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin [J]. J Am Soc Nephrol, 1995, 6(4):1186-1196.
6. Shihab FS, Bennett WM, Tanner AM, et al. Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy [J]. Kidney Int, 1997, 52(3):660-673.
7. Wu P, Guo Z, Zhang Y, et al. Aldosterone overproduction and CYP11B2 mRNA overexpression in vessels of spontaneously hypertensive rats [J]. Horm Res, 1998, 50(1):28-33. (Pubitemid 28352116)
8. Gomez-Sanchez EP, Ahmad N, Romero DG, et al. Is aldosterone synthesized within the rat brain [J]. Am J Physiol Endocrinol Metab, 2005, 288(2):E342-E346. (Pubitemid 40110641)
9. Wu P, Liang X, Dai Y, et al. Aldosterone biosynthesis in extraadrenal tissues [J]. Chin Med J (Engl), 1999, 112 (5):414-418.
10. Greenman Y, Trostanetsky Y, Ben-Shemen S, et al. Thyroid cysts; a new extra-adrenal site of aldosterone synthase expression and increased aldosterone content [J]. Clin Endocrinol (Oxf), 2007, 66(6):886-889. (Pubitemid 47024276)
11. Xue C, Siragy HM. Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor [J]. Hypertension, 2005, 46(3):584-590. (Pubitemid 41379384)